US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Immunotherapy market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Immunotherapy market." Immunotherapy is the treatment given to suppress or amplify the immune response of a person using immunomodulators. The amplification of immune response is called as activation immunotherapy and the suppression of the immune response is called suppression immunotherapy. The global Immunotherapy market is valued at 106900 million US$ in 2018 is expected to reach 179100 million US$ by the end of 2025, growing at a CAGR of 6.7% during 2019-2025. This report focuses on Immunotherapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Immunotherapy market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Abbvie Amgen, Inc. Biogen Bristol-Myers Squibb Celgene Johnson & Johnson Merck Novartis Pfizer Roche Segment by Regions North America Europe China Japan Segment by Type Monoclonal Antibodies Therapeutic Vaccines Checkpoint Inhibitors Non-Specific Immunotherapy Segment by Application Oncology Inflammation Central Nervous System Others
Table of Contents Executive Summary 1 Immunotherapy Market Overview 1.1 Product Overview and Scope of Immunotherapy 1.2 Immunotherapy Segment by Type 1.2.1 Global Immunotherapy Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Monoclonal Antibodies 1.2.3 Therapeutic Vaccines 1.2.4 Checkpoint Inhibitors 1.2.5 Non-Specific Immunotherapy 1.3 Immunotherapy Segment by Application 1.3.1 Immunotherapy Consumption Comparison by Application (2014-2025) 1.3.2 Oncology 1.3.3 Inflammation 1.3.4 Central Nervous System 1.3.5 Others 1.4 Global Immunotherapy Market by Region 1.4.1 Global Immunotherapy Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Immunotherapy Market Size 1.5.1 Global Immunotherapy Revenue (2014-2025) 1.5.2 Global Immunotherapy Production (2014-2025) 2 Global Immunotherapy Market Competition by Manufacturers 2.1 Global Immunotherapy Production Market Share by Manufacturers (2014-2019) 2.2 Global Immunotherapy Revenue Share by Manufacturers (2014-2019) 2.3 Global Immunotherapy Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Immunotherapy Production Sites, Area Served, Product Types 2.5 Immunotherapy Market Competitive Situation and Trends 2.5.1 Immunotherapy Market Concentration Rate 2.5.2 Immunotherapy Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Immunotherapy Production Market Share by Regions 3.1 Global Immunotherapy Production Market Share by Regions 3.2 Global Immunotherapy Revenue Market Share by Regions (2014-2019) 3.3 Global Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Immunotherapy Production 3.4.1 North America Immunotherapy Production Growth Rate (2014-2019) 3.4.2 North America Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019) 3.5 Europe Immunotherapy Production ... | read more...